Donate to save aHUS lives
aHUS is a devastating, ultra-rare blood disease that kills 10 per cent of patients within the first year of diagnosis, and 32 per cent within four years.
Soliris (eculizumab) is the only available, proven treatment that can ultimately save aHUS lives.
However, without government subsidy, this cost-prohibitive treatment remains out of reach of the less than 30 Australians known to be living with aHUS.
Your generous support will help fund Soliris for Australians living with this devastating disease and allow us to continue to rally the government for urgent access to this life-saving treatment.
Please make a tax-deductible, life-saving donation to the aHUS Patient Support Group Australia (aPSGA) today.
Thank you for helping to save the lives of Australians living with aHUS.